rs2608053
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
rs3806624
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis.
|
24149102 |
2013 |
rs3806624
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis.
|
24149102 |
2013 |
rs501764
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs501764
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs501764
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
rs501764
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
rs6439924
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
rs6439924
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
rs6903608
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
rs6903608
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
rs6903608
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs6903608
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs6903608
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
rs6903608
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
rs6903608
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
rs7745098
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis.
|
24149102 |
2013 |
rs7745098
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis.
|
24149102 |
2013 |
rs649775
|
|
Hodgkin Disease
|
|
0.710 |
GeneticVariation
|
BEFREE |
We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>).
|
30194254 |
2018 |
rs649775
|
|
Hodgkin Disease
|
A |
0.710 |
GeneticVariation
|
GWASCAT |
We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>).
|
30194254 |
2018 |
rs1002658
|
|
Hodgkin Disease
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
We identify 5 new HL risk loci at 6p21.31 (rs649775; <i>P</i> = 2.11 × 10<sup>-10</sup>), 6q23.3 (rs1002658; <i>P</i> = 2.97 × 10<sup>-8</sup>), 11q23.1 (rs7111520; <i>P</i> = 1.44 × 10<sup>-11</sup>), 16p11.2 (rs6565176; <i>P</i> = 4.00 × 10<sup>-8</sup>), and 20q13.12 (rs2425752; <i>P</i> = 2.01 × 10<sup>-8</sup>).
|
30194254 |
2018 |
rs1046089
|
|
Hodgkin Disease
|
G |
0.700 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs11715604
|
|
Hodgkin Disease
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
|
28112199 |
2017 |
rs1244186
|
|
Hodgkin Disease
|
A |
0.700 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
rs12638862
|
|
Hodgkin Disease
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
|
28112199 |
2017 |